(OTCBB:PURO), (Nasdaq:CROX), (OTC BB:NNBP).

RealPennies.com: Turning Pennies into dollars: (OTCBB:PURO), (Nasdaq:CROX), (OTC BB:NNBP).

Are you a public company looking for exposure?
Contact RealPennies.com - 1.800.940.6559

For more info: http://puro.realpennies.com

Blaine WA, Purio Environmental Water Source, Inc. (OTCBB:PURO)(February 4, 2008), has made a Patent Cooperation Treaty patent application for a compact, light weight, high capacity multi-stage water clarifier. The PCT application covers all of the member countries - 137 of them as of July 2007 including industrialized nations and many developing countries considered high priority marketing opportunities for the Company.

According to Joseph A.M Swanson, Vice President and Chief Operations Officer of Purio, the clarifier's design represents a giant step forward for the Company in that its light weight makes it highly transportable for mobile cap situations and other applications where portability is important. Its compact design enhances its suitability to work in limited spaces such as in densely populated urban areas, ships' holds, and existing buildings requiring retrofit of potable or waste water-systems. The new compact unit, although more space efficient than that existing Purio Clarifier is designed to exceed its throughput capabilities.

The first of the new units should be built and tested within the next six months and be ready for commercial use shortly after that.

For more info: http://crox.realpennies.com

Crocs, Inc (Nasdaq:CROX) (February 1, 2008) officially launched SolesUnitedSM, the first-of-its-kind recycled footwear donation program dedicated to providing new quality footwear to people in need worldwide. With support from a network of shipping and charity partners like Brothers Brother Foundation and Feed The Children, Crocs is determined to make a positive difference, setting a goal of donating two million pairs of recycled Crocs shoes to those in need in 2008. Crocs, Inc. and its subsidiaries design, develop, and manufacture consumer products from specialty resins worldwide. It offers footwear for men, women, and children under the crocs brand.

The company also offers apparel and accessories, including t-shirts, sweatshirts, hats, beanies, and socks. In addition, it manufactures spa pillows for the home spa market; seats and pads for use in kayaks and canoes; and scuba diving fins for other water sports products, as well as produces and distributes hockey and lacrosse equipment. It sells its products through other specialty channels, including gift shops, uniform suppliers, independent bicycle dealers, specialty food retailers, health and beauty stores, and other specialty stores. Crocs also sells its products through company-operated kiosks that are located in high foot traffic areas, and directly to consumers through its Web site, crocs.com. The company operates in Australia, Austria, the Caribbean, France, Germany, Hong Kong, Japan, the Netherlands, Singapore, and the United Kingdom. As of December 31, 2006, it operated 83 retail kiosks, as well as approximately 11,000 store locations in the United States. The company was founded as Western Brands, LLC in 1999 and changed its name to Crocs, Inc. in 2005. Crocs is headquartered in Niwot, Colorado.

For more info: http://nnbp.realpennies.com

Nanobac Pharmaceuticals Inc (OTC BB:NNBP) (February 1, 2008) is pleased to announce a jointly signed letter of intent for the acquisition of DNAPrint Genomics, Inc. (OTCBB:DNAG - News) ("DNAPrint" or DNAP). With the acquisition, which is subject to DNAPrint Genomics shareholder approval, Nanobac becomes one of a select group of next-generation drug and diagnostics developers, applying advanced computational methods and systematic genome-based approaches to streamline clinical product development.

Nanobac adds advanced drug and diagnostics development programs, key patents and patent applications, and a proprietary product modeling platform to its existing initiatives, and expands its focus into multiple disease sites for both Diagnostics and Therapeutics.

Nanobac Pharmaceuticals, Incorporated, a bio-lifescience company, engages in the discovery and development of products and services to improve human health through the detection and treatment of calcifying nanoparticles (CNPs). It offers ?in vitro diagnostic' (IVD) kits, such as assays, antibodies, and reagents for detecting calcifying nanoparticles. The company's diagnostic assays comprise NANO-CAPTURE and NANO-SERO.

Additionally, it conducts research and clinical studies in the development of urological diseases, including chronic prostatitis/chronic pelvic pain syndrome, kidney stones, and polycystic kidney diseases. Nanobac Pharmaceuticals was founded in 1994 and is headquartered in Tampa, Florida.

Read our full disclaimer at: http://www.realpennies.com/start.html

Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on RealPennies. For more movers: http://www.realpennies.com/wrapup.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice.
Sitemap: http://www.realpennies.com/sitemap.html

RealPennies .

Telephone: 1-800-940-6559

Matt /at/ realpennies.com